Steven Valiquette
Stock Analyst at Mizuho
(2.75)
# 1,964
Out of 4,745 analysts
103
Total ratings
56.6%
Success rate
2.93%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VEEV Veeva Systems | Maintains: Outperform | $275 → $280 | $223.40 | +25.34% | 2 | Dec 9, 2024 | |
LFMD LifeMD | Initiates: Neutral | $7 | $5.13 | +36.45% | 1 | Dec 4, 2024 | |
DOCS Doximity | Initiates: Neutral | $55 | $56.56 | -2.76% | 1 | Dec 4, 2024 | |
HQY HealthEquity | Initiates: Outperform | $126 | $106.88 | +17.89% | 1 | Dec 4, 2024 | |
XRAY DENTSPLY SIRONA | Initiates: Neutral | $21 | $19.53 | +7.53% | 6 | Dec 4, 2024 | |
HSIC Henry Schein | Initiates: Neutral | $75 | $74.97 | +0.04% | 5 | Dec 4, 2024 | |
SOLV Solventum | Initiates: Neutral | $70 | $74.99 | -6.65% | 1 | Dec 4, 2024 | |
TALK Talkspace | Initiates: Outperform | $5 | $3.20 | +56.25% | 1 | Dec 4, 2024 | |
NVST Envista Holdings | Initiates: Underperform | $20 | $21.45 | -6.76% | 1 | Dec 4, 2024 | |
OMI Owens & Minor | Maintains: Equal-Weight | $18 → $14 | $14.94 | -6.29% | 7 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $185.77 | -23.56% | 10 | Sep 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $60.82 | -9.57% | 6 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $136.75 | -32.72% | 10 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $128.83 | -34.02% | 5 | Jun 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $532.51 | +6.10% | 5 | Apr 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $54.55 | +83.32% | 1 | Mar 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.69 | +198.51% | 1 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $304.33 | +31.44% | 4 | Oct 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $64.58 | +65.69% | 1 | Jul 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $26.91 | -36.83% | 3 | Apr 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $4.92 | +143.90% | 1 | Jun 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $475 → $555 | $233.30 | +137.89% | 9 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $95.65 | +0.37% | 3 | Nov 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $166 | $591.58 | -71.94% | 2 | Nov 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $155.28 | -22.72% | 6 | Apr 30, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $313.07 | -59.43% | 1 | Apr 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $294.63 | +21.51% | 3 | Dec 6, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $20 → $16 | $30.93 | -48.27% | 3 | Aug 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $11.87 | +405.48% | 3 | Apr 3, 2019 |
Veeva Systems
Dec 9, 2024
Maintains: Outperform
Price Target: $275 → $280
Current: $223.40
Upside: +25.34%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $5.13
Upside: +36.45%
Doximity
Dec 4, 2024
Initiates: Neutral
Price Target: $55
Current: $56.56
Upside: -2.76%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $106.88
Upside: +17.89%
DENTSPLY SIRONA
Dec 4, 2024
Initiates: Neutral
Price Target: $21
Current: $19.53
Upside: +7.53%
Henry Schein
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $74.97
Upside: +0.04%
Solventum
Dec 4, 2024
Initiates: Neutral
Price Target: $70
Current: $74.99
Upside: -6.65%
Talkspace
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $3.20
Upside: +56.25%
Envista Holdings
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $21.45
Upside: -6.76%
Owens & Minor
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $14.94
Upside: -6.29%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $185.77
Upside: -23.56%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $60.82
Upside: -9.57%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $136.75
Upside: -32.72%
Jun 12, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $128.83
Upside: -34.02%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $532.51
Upside: +6.10%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $54.55
Upside: +83.32%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.69
Upside: +198.51%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $304.33
Upside: +31.44%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $64.58
Upside: +65.69%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $26.91
Upside: -36.83%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $4.92
Upside: +143.90%
Feb 4, 2021
Maintains: Equal-Weight
Price Target: $475 → $555
Current: $233.30
Upside: +137.89%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $95.65
Upside: +0.37%
Nov 2, 2020
Upgrades: Overweight
Price Target: $166
Current: $591.58
Upside: -71.94%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $155.28
Upside: -22.72%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $313.07
Upside: -59.43%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $294.63
Upside: +21.51%
Aug 30, 2019
Maintains: Underweight
Price Target: $20 → $16
Current: $30.93
Upside: -48.27%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $11.87
Upside: +405.48%